Application of γPGA (TLR4 ligand) reduces AD symptoms, basophil population, and Th2 cytokines levels and upregulates Th1 cytokines through the TLR4/DC/IL12 axis in mice models of AD [158]. The gene discussed is TLR4; the disease is Alzheimer disease.